Idebenone + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Leber's Hereditary Optic Neuropathy
Conditions
Leber's Hereditary Optic Neuropathy
Trial Timeline
Nov 1, 2007 → Feb 1, 2010
NCT ID
NCT00747487About Idebenone + Placebo
Idebenone + Placebo is a phase 2 stage product being developed by Santhera Pharmaceuticals for Leber's Hereditary Optic Neuropathy. The current trial status is completed. This product is registered under clinical trial identifier NCT00747487. Target conditions include Leber's Hereditary Optic Neuropathy.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (5)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01495715 | Phase 3 | Withdrawn |
| NCT01303406 | Phase 3 | Completed |
| NCT00747487 | Phase 2 | Completed |
| NCT00905268 | Phase 3 | Completed |
| NCT00654784 | Phase 2 | Completed |
Competing Products
4 competing products in Leber's Hereditary Optic Neuropathy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Idebenone | Santhera Pharmaceuticals | Approved | 77 |
| Idebenone 150 MG Oral Tablet | Santhera Pharmaceuticals | Pre-clinical | 15 |
| Idebenone | Santhera Pharmaceuticals | Pre-clinical | 15 |
| Idebenone + Placebo | Santhera Pharmaceuticals | Phase 3 | 69 |